HuMax-CD38, a new human CD38 monoclonal antibody, effectively mediates killing of multiple myeloma and plasma cell leukemia cells. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.740. Disponível em: https://journals.pagepress.org/hmr/article/view/740. Acesso em: 20 jun. 2025.